MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by IKEDA, M.
Right arrow Articles by KATAYAMA, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by IKEDA, M.
Right arrow Articles by KATAYAMA, T.

Molecular Pharmacology, Vol 4, 38-43, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics

Inhibitory Effect of 2-Diethylaminoethyl 2,2-Diphenylvalerate Hydrochloride (SKF 525-A) on Aromatic Hydroxylation and Phenolic Glucuronidation

MASAYUKI IKEDA 1, SHIRO TANAKA 1, and TOMOKO KATAYAMA 1

1 Department of Public health, Faculty of Medicine, Kyoto University, Kyoto, Japan

Kinetics of the inhibition of two microsomal enzymes of guinea pig liver by SKF 525-A was studied; namely, aryl 4-hydroxylase toward aniline and UDP-glucuronyl transferase toward phenolic glucuronidation of o-aminophenol. In vitro conversion from aniline to p-aminophenol by aryl 4-hydroxylase was noncompetitively inhibited with Ki of 1.7 x 10-4 M, while apparent Km of the reaction was 1.8 x 10-3 M. Excretion of phenol or p-aminophenol in the urine of rats and guinea pigs treated with benzene or aniline, respectively, was markedly decreased by the simultaneous injection of SKF 525-A, indicating the inhibitor was effective in vivo as well as in vitro. Formation of o-aminophenyl glucuronide by UDP-glucuronyl transferase in vitro had apparent Km of 7.1 x 10-5 M, and was inhibited by SKF 525-A also in a noncompetitive manner with Ki of 3.6 x 10-4 M. The in vivo effect of the inhibitor on phenolic glucuronidation was demonstrated with rats and guinea pigs.

Note:
ACKNOWLEDGMENTS SKF 525-A was a gift from Smith, Kline and French Laboratories, Philadelphia, Pennsylvania. This work was supported in part by a grant from the Fujiwara Memorial Fund.

Submitted on April 13, 1967
Revised on July 13, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics